Abzena Supplies Clinical Trial Material For Angiex`s AGX101 Study
08 Aug 2024 //
PR NEWSWIRE
Angiex Doses First Patient In Phase 1 Trial Of AGX101 For Solid Tumors
07 Aug 2024 //
GLOBENEWSWIRE
08 Aug 2024 //
PR NEWSWIRE
07 Aug 2024 //
GLOBENEWSWIRE